Phase 2 Parkinson's Disease Trial, Not Yet Recruiting NCT07366411 Sponsor: Universidade Federal de Pernambuco Condition: Parkinson's Disease
Back to Parkinsons Disease

Phase 2 Parkinson's Disease Trial, Not Yet Recruiting

NCT07366411
Not Yet Recruiting Phase 2

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • A neurologist has formally diagnosed the person with Parkinson's disease.
  • The person has been taking Parkinson's medication regularly and at a stable dose for at least three months.
  • The person is aged 40 years or older.
  • The person's Parkinson's disease falls within a moderate to moderately severe range of progression, as measured by a scale called the Hoehn & Yahr stage (specifically stages 2.5 to 4).

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • The person has other neurological conditions, low blood pressure when standing, inner ear (balance) problems, bone or muscle disorders, or vision problems that could affect their ability to complete the trial's tests.
  • The person has bone, joint, or muscle conditions in their legs that affect their ability to move or walk normally.
  • The person scores lower than 21 out of 30 on a standard memory and thinking assessment called the Montreal Cognitive Assessment (MoCA).
  • The person has previously had surgery as a treatment for Parkinson's disease.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 10 July 2026

Contact this trial

Principal Investigator: Kátia Monte-Silva, Phd in neurosciences, Universidade Federal de Pernambuco

Phone: +5581986450112

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Phase 2
Sponsor
Universidade Federal de Pernambuco
Registry
ClinicalTrials.gov
Start date
15 February 2026
Est. completion
15 March 2027

Where this trial is recruiting

🇧🇷 Brazil

Primary endpoints

Functional mobility

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 10 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov